Global BioPharma Leader Saves Up To $30MM Per Year With Model N

"Model N Global Pricing reduced our average year-on-year price erosion in Europe by 40%."

-Head of International Pricing
Fortune 500 Global BioPharma Company

This global biologics leader’s legacy system lacked capabilities to satisfy regulatory requirements or coordinate complex price changes and global product launches, and exposed the manufacturer to weak negotiating positions with Ministries of Health.

Read how this top 5 global biopharma manufacturer reduced year-on-year price erosion in Europe by up to 40% with Model N Global Pricing.